Boston Leasing & Finance reports standalone net profit of Rs 0.01 crore in the September 2018 quarter
Drug firm Pfizer on Thursday reported a standalone net profit of Rs 131.94 crore for the third quarter ended December 2018.
It had reported a net profit of Rs 87.24 crore in the October-December quarter of the last financial year, Pfizer said in a BSE filing.
Pfizer's total income was Rs 578.14 crore during the quarter under review. It was Rs 488.62 crore in the corresponding quarter a year ago.
Meanwhile, the company said that its result was not comparable as sales for the nine months ended December 2017 include excise duty up to June 30, 2017.
Pfizer's total expenses stood at Rs 377.52 crore.
Shares of Pfizer Ltd on Thursday settled at Rs 2,681.50 on BSE, up 0.62 per cent from their previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)